EUVIMEDEUVIMED entdecken
Crossref

Oxaliplatin accelerates immunogenic cell death by activating the cGAS / STING / TBK1 / IRF5 pathway in gastric cancer

Siwei Zhao, Dong Sun, Hang Yu, Menglin Wang, Botao Xu, Yufei Wang, Fangqi Hu, Xiaofeng Wang, Jiazi Zhang, Yongsheng Wang iD, Jie Chai iD

The FEBS Journal · 2025-07 · 292 (14) · 3814-3828

DOI: 10.1111/febs.70102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, online erschienen am 22.04.2025. Verfasst von Siwei Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sci…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Oxaliplatin, Protein Serine-Threonine Kinases, Nucleotidyltransferases. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Shandong Provincial Natural Science Foundation, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunogenic cell death is a tumor cell death involving both innate and adaptive immune responses. Given the published findings that oxaliplatin causes the secretion of high mobility group box 1 (HMGB1) from cancer cells, which is necessary for the initiation of immunogenic cell death, we investigated whether oxaliplatin plays an anticancer role in gastric cancer by inducing immunogenic cell death and further explored its mechanism. We found that oxaliplatin inhibited viability and induced pyroptosis, immunogenic cell death, the production of reactive oxygen species, mitochondrial permeability transition pore (mPTP) opening, and cyclic GMP‐AMP synthase (cGAS)–stimulator of interferon genes (STING) axis activation in gastric cancer cells. Suppressing mPTP opening (cyclosporine treatment), depleting mitochondrial DNA (mtDNA; ethidium bromide treatment), or STING downregulation (H151 or si‐STING treatment) reversed cGAS/STING pathway activation and the increased immunogenic cell death induced by oxaliplatin in MKN‐45 and AGS cells. Moreover, oxaliplatin induced immunogenic cell death via activating the cGAS/STING/TANK‐binding kinase 1 (TBK1; also known as serine/threonine‐protein kinase TBK1)/interferon regulatory factor 5 (IRF5) pathway. In conclusion, oxaliplatin treatment could induce immunogenic cell death and mPTP opening and activate the cGAS/STING/TBK1/IRF5 pathway in gastric cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsOxaliplatinProtein Serine-Threonine KinasesNucleotidyltransferasesMembrane ProteinsImmunogenic Cell DeathInterferon Regulatory FactorsAntineoplastic AgentsHumansCell Line, TumorSignal TransductionReactive Oxygen SpeciesMitochondrial Permeability Transition PorePyroptosisCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseSTING Protein

Stichwörter der Autor:innen

cGAS/STING/TBK1/IRF5 pathwaygastric cancerimmunogenic cell deathmPTP openingoxaliplatin

Substanzen

OxaliplatinProtein Serine-Threonine KinasesNucleotidyltransferasesMembrane ProteinsInterferon Regulatory FactorsReactive Oxygen SpeciesMitochondrial Permeability Transition PoreAntineoplastic AgentscGAS protein, humanCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Department of Plastic Surgery, The First Affiliated Hospital, Dalian Medical University, China.
  • Department of Breast Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.

ORCID-Profile: Yongsheng Wang, Jie Chai

Förderung

  • Shandong Provincial Natural Science Foundation
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Zhao, S., Sun, D., Yu, H., Wang, M., Xu, B., Wang, Y., Hu, F., Wang, X., Zhang, J., Wang, Y., & Chai, J. (2025). Oxaliplatin accelerates immunogenic cell death by activating the cGAS / STING / TBK1 / IRF5 pathway in gastric cancer. The FEBS Journal, 292(14), 3814-3828. https://doi.org/10.1111/febs.70102

Vancouver

Zhao S, Sun D, Yu H, Wang M, Xu B, Wang Y, et al. Oxaliplatin accelerates immunogenic cell death by activating the cGAS / STING / TBK1 / IRF5 pathway in gastric cancer. The FEBS Journal. 2025;292(14):3814-3828. doi:10.1111/febs.70102

BibTeX
@article{Zhao2025,
  author = {Zhao, Siwei and Sun, Dong and Yu, Hang and Wang, Menglin and Xu, Botao and Wang, Yufei and Hu, Fangqi and Wang, Xiaofeng and Zhang, Jiazi and Wang, Yongsheng and Chai, Jie},
  title = {Oxaliplatin accelerates immunogenic cell death by activating the cGAS / STING / TBK1 / IRF5 pathway in gastric cancer},
  journal = {The FEBS Journal},
  year = {2025},
  volume = {292},
  number = {14},
  pages = {3814--3828},
  doi = {10.1111/febs.70102}
}
Kostenlos starten →